Kornélia Tekes

Semmelweis University — Hungary

Neuroscience · Life Sciences

28h-index2.3kcitations164works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(35), Neurotransmitter Receptor Influence on Behavior(26), Pesticide Exposure and Toxicity(22), Cholinesterase and Neurodegenerative Diseases(17), Receptor Mechanisms and Signaling(14)

Publications164 total

An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
International Journal of Molecular Sciences·2023· 44 citedOpen Access
Acetylcholinesterase and Association 1 of ACHE 3’ UTR SNP rs17228602 with Psychiatric Disorders
Kuwait Journal of Science·2022· 2 citedOpen Access
Investigation of the Experimental Pharmacokinetics of the Bis-Chlorinated Bis-pyridinium Mono-aldoxime Cholinesterase Reactivator K-868 in Rats
The Open Medicinal Chemistry Journal·2021Open Access
Nociceptin Increases Antioxidant Expression in the Kidney, Liver and Brain of Diabetic Rats
Biology·2021· 12 citedOpen Access
Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development
Expert Opinion on Investigational Drugs·2020· 18 cited
Pharmacokinetics of a Mono-pyridinium-mono-aldoxime (K-347), a Potential Antidote in Organophosphate Poisoning
The Open Medicinal Chemistry Journal·2020· 1 citedOpen Access
A fieldable, high-throughput, cost-efficient high performance liquid chromatography-ultraviolet absorption detection (HPLC-UV) method for the quantitation of bispyridinium quaternary aldoxime cholinesterase reactivators in blood
Acta Chromatographica·2020· 5 citedOpen Access
Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase
Molecules·2020· 3 citedOpen Access
An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
Expert Opinion on Investigational Drugs·2019· 23 cited
Pharmacokinetics of K117 and K127, two novel antidote candidates to treat Tabun poisoning
Chemico-Biological Interactions·2019· 3 cited
An update on therapies for the treatment of diabetes-induced osteoporosis
Expert Opinion on Biological Therapy·2019· 128 cited
Dose-Dependent Tissue Distribution of K117, a Bis-pyridinium Aldoxime, in Rats
The Open Medicinal Chemistry Journal·2019· 3 citedOpen Access
Circulating nociceptin and CGRP in medication‐overuse headache
Acta Neurologica Scandinavica·2018· 17 cited
PHARMACOKINETICS OF BIS-PYRIDINIUM MONO-ALDOXIMES
MMSL·2018
ANALYSIS OF BIS-PYRIDINIUM MONO-ALDOXIMES IN SERUM AND ORGANS USING A HIGH-THROUGHPUT HIGH PERFORMANCE LIQUID CHROMATOGRAPHY APPROACH
MMSL·2018
Effect of nociceptin on insulin release in normal and diabetic rat pancreas
Cell and Tissue Research·2018· 12 cited
Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease
The Open Medicinal Chemistry Journal·2018· 8 citedOpen Access
Effects on Sperms’ Quality of Selegiline in Aged Rats
The Open Medicinal Chemistry Journal·2017· 2 citedOpen Access
Novel biological therapies for the treatment of diabetic foot ulcers
Expert Opinion on Biological Therapy·2017· 47 cited
Monitoring the Level of 14C-Labelled Selegiline Following Oral Administration
The Open Medicinal Chemistry Journal·2017· 2 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Huba Kalász(17), Ernest Adeghate(10), K. Magyar(10), László Tóthfalusi(9), Mónika Hantos(8), Georg Petroianu(7), G. Csaba(5), Miklós Palkovits(4), Syed M. Nurulain(4), Kamil Kuča(4), Krisztina Ludányi(4), Melinda Gyenge(3), Mihály Arató(3), Duncan J. MacCrimmon(3), Jennifer Adeghate(3), Gábor Faludi(3), Ferenç Szalay(3), Csaba Ertsey(3), Dietrich E. Lorke(2), Sahar Mohsin(2)